Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Feb 20:10:9.
doi: 10.1186/s40545-017-0099-5. eCollection 2017.

Capacity for ethical and regulatory review of herbal trials in developing countries: a case study of Moringa oleifera research in HIV-infected patients

Tsitsi G Monera-Penduka  1 , Charles C Maponga  1 , Gene D Morse  2 , Charles F B Nhachi  3
Affiliations

Capacity for ethical and regulatory review of herbal trials in developing countries: a case study of Moringa oleifera research in HIV-infected patients

Tsitsi G Monera-Penduka et al. J Pharm Policy Pract. .

Abstract

Background: Lack of regulatory capacity limits the conduct of ethical and rigorous trials of herbal medicines in developing countries. Sharing ethical and regulatory experiences of successful herbal trials may accelerate the field while assuring human subjects protection. The methods and timelines for the ethical and regulatory review processes for the first drug regulatory authority approved herbal trial in Zimbabwe are described in this report.

Methods: The national drug regulatory authority and ethics committee were engaged for pre-submission discussions. Six applications were submitted. Application procedures and communications with the various regulatory and ethics review boards were reviewed. Key issues raised and timelines for communications were summarized.

Results: There was no special framework for the approval of herbal trials. One local institutional review committee granted an exemption. Key issues raised for revision were around pre-clinical efficacy and safety data, standardization and quality assurance of the intervention as well as consenting procedures. Approval timelines ranged between eight and 72 weeks.

Conclusions: In the absence of a defined framework for review of herbal trials, approval processes can be delayed. Dialogue between researchers and regulators is important for successful and efficient protocol approval for herbal trials in developing countries.

Trial registration: The study was registered prospectively on August 3, 2011 with clinicaltrials.gov (NCT01410058).

Keywords: Developing countries; Herbal trial; Regulation.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Time taken to obtain approvals. The black bars represent the time taken by the reviewer, while the grey bars represent the researcher’s response time
See this image and copyright information in PMC

References

    1. Siegfried NL, Hughes G. Herbal medicine, randomised controlled trials and global core competencies. S Afr Med J. 2012;102(12):912–3. doi: 10.7196/SAMJ.6392. - DOI - PubMed
    1. Willcox M, Siegfried N, Johnson Q. Capacity for clinical research on herbal medicines in Africa. J Altern Complement Med. 2012;18(6):622–8. doi: 10.1089/acm.2011.0963. - DOI - PMC - PubMed
    1. Davies J, Mullan Z. Research capacity in Africa—will the sun rise again? Lancet Glob Health. 2016;4(5):e287. doi: 10.1016/S2214-109X(16)30046-8. - DOI - PubMed
    1. Tilburt JC, Kaptchuk TJ. Herbal medicine research and global health: an ethical analysis. Bull World Health Organ. 2008;86(8):594–9. doi: 10.2471/BLT.07.042820. - DOI - PMC - PubMed
    1. Koonrungsesomboon N and Karbwang J. Ethical considerations in clinical research on herbal medicine for prevention of cardiovascular disease in the ageing. Phytomed. 2015;doi: 10.1016/j.phymed.2015.10.017. - PubMed

Associated data

LinkOut - more resources